Pseudorabies / Aujeszky's (swine)

Pseudorabies, also known as Aujeszky's disease, is a highly contagious viral disease caused by Suid herpesvirus 1, a member of the Alphaherpesvirinae subfamily. This devastating neurological condition primarily affects swine, which serve as the natural reservoir host for the virus. The disease was first described by Hungarian veterinarian Aladár Aujeszky in 1902 and has since been recognized as one of the most economically significant diseases affecting the global swine industry. Despite its name, pseudorabies is not related to the rabies virus but was named for the similar clinical signs of intense itching and neurological dysfunction observed in affected animals.

Swine are the only species that can survive infection and become carriers of the pseudorabies virus, making them the critical link in disease transmission and maintenance. While pigs may recover from infection, they typically become lifelong latent carriers capable of shedding the virus during periods of stress. Other species, including cattle, sheep, goats, dogs, cats, and various wildlife species, are considered dead-end hosts, meaning they cannot transmit the virus to other animals but invariably die from infection. The disease does not affect humans, though laboratory workers handling the virus should take appropriate precautions.

The economic impact of pseudorabies on the swine industry has historically been enormous, causing losses through direct mortality, reduced reproductive performance, decreased weight gain, and trade restrictions. In breeding herds, the virus causes reproductive failure including abortions, stillbirths, mummified fetuses, and weak piglets. Young piglets infected before three weeks of age experience nearly 100 percent mortality, while older pigs may develop respiratory disease and reduced growth rates. Many countries have implemented expensive eradication programs to eliminate the disease, with the United States successfully eradicating pseudorabies from commercial swine herds in 2004 after decades of effort.

Early detection and rapid response are critical when pseudorabies is suspected because of the highly contagious nature of the virus and its status as a reportable disease in most countries. Veterinary authorities must be notified immediately upon suspicion of infection, and strict quarantine measures must be implemented to prevent spread. While there is no treatment for infected animals, vaccination programs and biosecurity measures have proven effective at controlling and eventually eradicating the disease from domestic swine populations. Understanding this disease remains important because wild and feral swine populations continue to harbor the virus and pose an ongoing threat to domestic swine production.

Pseudorabies is caused by Suid herpesvirus 1 (SuHV-1), also known as pseudorabies virus (PRV) or Aujeszky's disease virus. This DNA virus belongs to the family Herpesviridae and the subfamily Alphaherpesvirinae, which also includes the human herpes simplex viruses. Like other alphaherpesviruses, PRV has the ability to establish latent infections in nervous tissue, allowing infected pigs to carry the virus for life without showing clinical signs. The virus is relatively stable in the environment and can survive for extended periods in cool, moist conditions, contaminated equipment, and biological materials such as meat products from infected animals.

There is no genetic predisposition to pseudorabies infection, as all breeds and genetic lines of swine are equally susceptible to the virus. However, the outcome of infection is heavily influenced by the age of the animal at the time of exposure. Neonatal piglets have virtually no resistance to infection and experience nearly universal mortality when exposed in the first two weeks of life. Older pigs develop increasing resistance with age, though they may still become infected and serve as carriers. The immune status of the dam can provide some protection to nursing piglets through colostral antibodies, though this passive immunity is temporary and incomplete.

Environmental and management factors play significant roles in the transmission and spread of pseudorabies virus. The virus spreads primarily through direct nose-to-nose contact between infected and susceptible pigs, though it can also spread through aerosol transmission over short distances, contaminated fomites, and infected semen used for artificial insemination. High-density housing, continuous farrowing systems, and the commingling of pigs from multiple sources all increase the risk of virus transmission within and between herds. Stress factors such as transportation, weather extremes, and concurrent infections can trigger virus shedding from latently infected carrier pigs.

The primary risk factors for pseudorabies introduction into a herd include the purchase of infected breeding stock, proximity to infected herds or feral swine populations, and inadequate biosecurity measures. Feral swine represent a persistent reservoir of infection in many regions, and contact between domestic and feral swine poses a significant risk for disease introduction. Wildlife species such as raccoons, opossums, and rodents can become infected through contact with infected pigs or contaminated materials and may spread the virus to other premises before dying from infection. Contaminated vehicles, equipment, and personnel can also serve as mechanical vectors for virus transmission between farms.

The pathophysiology of pseudorabies infection involves initial viral replication in the respiratory epithelium or tonsils following exposure. From these primary sites, the virus spreads to regional lymph nodes and subsequently to the central nervous system via peripheral nerves. In swine, the virus establishes latent infection in the trigeminal ganglia and other sensory ganglia, where it can persist for the lifetime of the animal. Reactivation of latent virus occurs periodically, particularly during times of stress, resulting in virus shedding and potential transmission to susceptible animals. In non-swine species, the rapid invasion of the central nervous system produces severe encephalitis and death before the animals can transmit the virus.

The clinical signs of pseudorabies vary dramatically depending on the age of the affected animal and the species involved. In swine, the disease manifests differently across age groups, ranging from hyperacute fatal disease in neonatal piglets to mild or subclinical infection in adult animals. Recognizing the early warning signs of pseudorabies is essential for rapid response and containment efforts. Initial symptoms in young piglets may include fever, lethargy, loss of appetite, and a characteristic high-pitched cry or vocalization that indicates neurological involvement. Affected piglets often seek out warm areas and may pile together, which can lead to crushing deaths in addition to direct disease mortality.

In piglets less than two weeks of age, pseudorabies typically produces severe and rapidly fatal neurological disease. Affected piglets develop high fever exceeding 41 degrees Celsius, followed quickly by central nervous system signs including tremors, incoordination, paddling movements, convulsions, and paralysis. The piglets may exhibit opisthotonus, where the head and neck are rigidly extended backward, and many develop a characteristic dog-sitting posture due to hindquarter weakness. Vomiting and profuse diarrhea frequently accompany the neurological signs. Death typically occurs within 24 to 48 hours of the onset of clinical signs, and mortality in this age group approaches 100 percent regardless of treatment attempts.

Older piglets between two and twelve weeks of age may show a wider range of clinical presentations, with mortality rates decreasing as age increases. These animals typically develop fever, depression, anorexia, and respiratory signs including sneezing, nasal discharge, and coughing. Neurological signs are common and may include incoordination, circling, head pressing, tremors, and convulsions, though they are generally less severe than in younger piglets. Some pigs in this age group develop constipation rather than diarrhea, and many show increased salivation and difficulty swallowing. Recovery is possible in older piglets, but survivors may experience permanent neurological deficits and will become latent carriers of the virus.

Adult breeding swine typically experience mild or subclinical infection, with the primary manifestation being reproductive failure. Pregnant sows infected with pseudorabies virus may abort at any stage of gestation, deliver stillborn or mummified piglets, or produce weak piglets that die shortly after birth. The timing of infection during pregnancy determines the outcome, with early gestation infection causing embryonic death and resorption, mid-gestation infection producing mummification, and late gestation infection resulting in stillbirths or weak newborns. Some infected sows show mild respiratory signs or fever, while others show no clinical signs despite ongoing virus shedding. Boars may develop temporary infertility due to fever-induced effects on spermatogenesis.

In cattle, sheep, goats, and other non-swine species, pseudorabies produces a distinctive and invariably fatal syndrome characterized by intense pruritus and rapid neurological deterioration. The intense itching, known as mad itch, causes affected animals to rub, bite, and scratch at a localized area of skin, typically on the head or limbs, until they create severe self-inflicted wounds. Cattle may scratch so vigorously that they remove large patches of skin and underlying tissue. Other signs include bellowing, aggressive behavior, hypersalivation, difficulty swallowing, and progressive paralysis. Death typically occurs within 24 to 72 hours of the onset of clinical signs, often preceded by convulsions and coma.

Emergency symptoms requiring immediate veterinary intervention and regulatory notification include any sudden onset of neurological signs in swine of any age, unexplained abortions or reproductive failure in breeding herds, intense pruritus with self-mutilation in cattle or sheep exposed to swine, and clusters of deaths in young piglets with tremors or convulsions. The highly contagious nature of pseudorabies and its regulatory status mean that any suspicion of this disease must trigger immediate isolation of affected animals, restriction of animal movement, and notification of veterinary authorities. Delaying response even by hours can allow widespread transmission within and between herds.

Clinical diagnosis of pseudorabies requires careful evaluation of the presenting signs in the context of species, age, and potential exposure history. The combination of sudden onset neurological disease in young pigs, reproductive failure in breeding herds, or intense pruritus with rapid death in cattle or other species exposed to swine should immediately raise suspicion for this reportable disease. Physical examination of affected swine may reveal high fever, increased respiratory rate, muscle tremors, abnormal gait, and altered consciousness ranging from depression to hyperexcitability. In non-swine species, the pathognomonic finding of intense localized itching with self-mutilation is highly suggestive of pseudorabies infection.

Laboratory confirmation of pseudorabies requires submission of appropriate samples to an approved diagnostic laboratory. In live animals, nasal and tonsillar swabs can be collected for virus isolation or polymerase chain reaction testing, though virus shedding may be intermittent in recovered or latently infected animals. Serological testing of blood samples using enzyme-linked immunosorbent assays or serum neutralization tests can detect antibodies to the virus, with different tests available to distinguish vaccinated from naturally infected animals. In countries with eradication programs, differential tests detecting antibodies to specific viral proteins allow identification of infected animals within vaccinated populations.

Necropsy and histopathological examination provide valuable diagnostic information, particularly in acutely affected animals. Gross findings may include congestion and edema of the brain and spinal cord, hemorrhages in various organs, and enlarged lymph nodes. In pregnant animals, examination of aborted fetuses and placentas may reveal characteristic lesions. Histopathological examination of brain tissue reveals nonsuppurative encephalitis with perivascular cuffing, gliosis, and intranuclear inclusion bodies in neurons and glial cells. Immunohistochemistry can detect viral antigens in tissue sections, and virus isolation from brain tissue remains the gold standard for definitive diagnosis.

Differential diagnosis must consider other causes of neurological disease, reproductive failure, and respiratory illness in swine and other livestock species. In swine, conditions producing similar signs include classical swine fever, African swine fever, porcine reproductive and respiratory syndrome, encephalomyocarditis virus infection, bacterial meningitis, and various toxic and metabolic disorders. In cattle and sheep, rabies must be distinguished from pseudorabies, though the intense pruritus of pseudorabies is not typically seen with rabies infection. Herd-level diagnostics including serological surveys of the breeding herd can help determine the prevalence and distribution of infection and guide response and control measures. All suspect cases should be reported to regulatory veterinary authorities, who will coordinate diagnostic testing and response activities.

There is no specific treatment or cure for pseudorabies in any species, and the primary approach to disease management focuses on prevention through vaccination and biosecurity. In non-swine species, infection is invariably fatal regardless of treatment attempts, and humane euthanasia should be considered once the diagnosis is confirmed or strongly suspected. In swine, supportive care may help some older animals survive infection, but there is no way to eliminate the virus from infected individuals. The regulatory status of pseudorabies as a reportable disease means that treatment decisions must be made in coordination with veterinary authorities, who may require depopulation of infected herds in areas with active eradication programs.

Emergency response to a suspected pseudorabies outbreak begins with immediate isolation of affected animals and restriction of all animal movement on and off the premises. Sick animals should be separated from healthy animals, and traffic patterns should be established to prevent cross-contamination between affected and unaffected areas. Personnel working with sick animals should use dedicated protective equipment and should not have contact with healthy animals without thorough cleaning and disinfection. Supportive care for affected swine may include providing a warm, dry environment, ensuring access to water and palatable feed, and administering anti-inflammatory medications to control fever, though these measures are unlikely to alter the outcome in severely affected animals.

Medical management options for pseudorabies are extremely limited because there are no antiviral drugs approved or effective for use against this infection. Antibiotics may be administered to prevent or treat secondary bacterial infections that commonly complicate respiratory disease in pigs, but they have no effect on the underlying viral infection. Anti-inflammatory drugs such as flunixin meglumine may help reduce fever and discomfort, but withdrawal times must be observed if animals are to enter the food chain. Any medications used in food-producing animals must be administered according to label directions or under veterinary prescription, with careful attention to appropriate withdrawal periods for meat and milk.

Supportive care measures focus on maintaining hydration, nutrition, and comfort while the animal's immune system responds to infection. Severely affected animals may require fluid therapy to combat dehydration from fever and reduced intake. Soft, palatable feeds may encourage eating in animals with reduced appetite or difficulty swallowing. Bedding should be deep and dry to protect recumbent animals from pressure sores and cold stress. Animals showing neurological signs may injure themselves or others, so housing should be designed to minimize hazards and allow safe handling. Pain management should be considered for animals showing signs of discomfort.

Herd-level treatment decisions in pseudorabies outbreaks are complex and must balance animal welfare, economic considerations, regulatory requirements, and disease control objectives. In countries with active eradication programs, infected herds may be subject to quarantine, mandatory testing, and potentially depopulation to prevent further spread. In areas where the disease is endemic, the goal may shift to controlling clinical disease and reducing economic losses through vaccination while accepting that the virus will persist in the population. Mass vaccination of sows and breeding stock can reduce reproductive losses and decrease the risk of clinical disease in offspring through passive immunity transfer.

The decision to treat individual animals versus culling must consider multiple factors including the age and value of the animal, severity of clinical signs, regulatory requirements, and the potential for recovered animals to serve as persistent carriers and sources of infection for naive animals. Young piglets with severe neurological signs have an extremely poor prognosis and are candidates for humane euthanasia. Adult breeding animals with mild signs may recover but will remain latently infected and should be considered for removal from the herd, particularly in herds attempting to eliminate infection. Economic analysis should consider the costs of treatment and lost production against the potential value of recovered animals and the risks associated with maintaining carriers in the herd.

Recovery from pseudorabies infection varies dramatically depending on the age and species of the affected animal. In non-swine species including cattle, sheep, goats, dogs, and cats, there is no recovery from infection, and death occurs within 24 to 72 hours of the onset of clinical signs in virtually all cases. In swine, the likelihood of recovery increases with age, with neonatal piglets experiencing nearly 100 percent mortality while adult animals typically survive infection. However, survival does not equal cure, as recovered pigs become latently infected carriers of the virus and represent an ongoing risk for transmission to susceptible animals.

The timeline for clinical recovery in surviving pigs depends on the severity of disease and the age at infection. Mild respiratory infections in older pigs may resolve within one to two weeks, while pigs recovering from neurological disease may require several weeks or months to regain normal function. Some recovered animals experience permanent neurological deficits including blindness, deafness, or gait abnormalities that may affect their productivity and welfare. Reproductive performance in recovered breeding animals may remain impaired for one or more breeding cycles following infection. Complete return to normal production levels may take several months, and some animals never fully recover their pre-infection productivity.

Post-treatment care and monitoring of recovered animals must account for their status as latent carriers of pseudorabies virus. Recovered pigs shed virus intermittently, particularly during periods of stress such as transportation, farrowing, or concurrent illness. These animals represent a persistent source of infection for susceptible herdmates, offspring, and other species on the farm. Monitoring should include regular clinical observation for signs of disease recurrence or transmission to contacts, serological testing to confirm infection status, and tracking of reproductive and growth performance. Strict biosecurity measures should be maintained to prevent virus spread from carrier animals.

Prognosis for individual animals depends primarily on age at infection and severity of clinical signs. Neonatal piglets have an extremely poor prognosis regardless of treatment. Older pigs with mild respiratory disease have a good prognosis for survival but will remain carriers. Animals with severe neurological involvement that survive may have permanent deficits affecting quality of life and productivity. The prognosis for the herd depends on the effectiveness of control measures and whether eradication or endemic control is the management goal. In endemic areas with vaccination programs, herds can return to productive operation while managing the continued presence of the virus.

Vaccination represents the cornerstone of pseudorabies prevention in swine populations where the disease is endemic or where exposure risk exists. Both modified-live and inactivated vaccines are available, with modified-live vaccines generally providing more robust protection but carrying theoretical risks in pregnant animals and immunocompromised individuals. Gene-deleted marker vaccines allow serological differentiation between vaccinated and naturally infected animals, facilitating surveillance and eradication efforts. Vaccination protocols typically include initial immunization of breeding stock with boosters before each breeding or farrowing, and vaccination of growing pigs at weaning. Piglets born to vaccinated dams receive passive protection through colostral antibodies, though this immunity wanes over several weeks.

Biosecurity measures are essential for preventing introduction of pseudorabies into naive herds and for controlling spread within and between premises. The foundation of biosecurity is controlling animal movement, with all incoming pigs tested or quarantined before introduction to the main herd. Isolation facilities should house new arrivals for at least 30 days with testing before and after the isolation period. Contact between domestic swine and feral or wild pigs must be strictly prevented through secure fencing, elimination of attractants, and avoidance of outdoor housing in areas with feral swine populations. Farm visitors, vehicles, and equipment can serve as mechanical vectors and should be subject to appropriate cleaning and disinfection protocols.

Nutritional management contributes to overall health and immune function, helping animals resist infection and respond optimally to vaccination. Well-nourished animals maintain stronger immune responses and are better able to withstand the challenges of infection if exposure occurs. Ensuring adequate protein, energy, vitamins, and minerals throughout all production stages supports robust immunity. Particular attention should be paid to nutrition during critical periods such as late gestation, lactation, and weaning when animals face increased nutritional demands and stress. Avoiding mycotoxin contamination of feeds is important as mycotoxins can suppress immune function.

Management practices that reduce stress and minimize opportunities for disease transmission help prevent pseudorabies and many other infectious diseases. All-in-all-out production systems with thorough cleaning and disinfection between groups prevent accumulation and transmission of pathogens. Maintaining appropriate stocking densities and ventilation reduces respiratory challenge and disease pressure. Minimizing stress from handling, transportation, and environmental extremes helps prevent virus reactivation and shedding from latently infected carriers. Good record keeping allows tracking of animal movements, vaccination status, and health events to facilitate rapid response if problems occur.

Quarantine and testing protocols provide the first line of defense against introducing pseudorabies into naive herds. All incoming animals should originate from sources with documented health status for pseudorabies, ideally from herds that are part of official surveillance and certification programs. Animals should be isolated and tested before joining the main herd, with retesting performed after the stress of transportation and adaptation. In areas with active eradication programs, herds may participate in official testing and certification schemes that provide documented assurance of freedom from infection. Ongoing surveillance through periodic serological testing of the breeding herd helps detect new infections early and maintain confidence in herd health status.

Daily management and monitoring of swine herds must incorporate awareness of pseudorabies risks and vigilance for early signs of infection. Producers should establish routines for observing animals daily, noting any changes in feed consumption, behavior, or physical condition that might indicate disease. In herds where pseudorabies is present or risk exists, particular attention should be paid to reproductive performance including conception rates, farrowing rates, litter sizes, and piglet survival. Any increase in abortions, stillbirths, or neonatal mortality should trigger immediate investigation. Personnel should be trained to recognize the clinical signs of pseudorabies and understand the importance of rapid reporting to management and veterinary authorities.

Housing and environmental management significantly influence pseudorabies transmission and control. Secure facilities that prevent contact between domestic pigs and wildlife or feral swine are essential, particularly in areas where wild reservoirs exist. Buildings should be designed to allow effective cleaning and disinfection, with smooth surfaces, adequate drainage, and access for power washing. Ventilation systems should provide fresh air while minimizing aerosol transmission between rooms or buildings. Climate control helps reduce stress and maintain animal health, particularly during temperature extremes. Loading and handling facilities should be designed to minimize contact with external sources of contamination.

Herd health programs for pseudorabies-endemic areas or at-risk herds should be developed in consultation with veterinary professionals and may include vaccination schedules, biosecurity protocols, and surveillance testing. The specific approach depends on whether the goal is control of clinical disease, gradual elimination through test-and-removal, or maintenance of certified freedom from infection. Breeding stock management is particularly important, as latently infected adults can transmit virus to their offspring and to other adults during breeding activities. Gilt and boar selection and introduction procedures should incorporate testing and quarantine protocols appropriate to the herd's health status and goals.

Record keeping and performance monitoring provide the foundation for effective pseudorabies management and early detection of problems. Key metrics to track include reproductive performance indicators such as farrowing rate, litter size, pre-weaning mortality, and number of mummified fetuses and stillborns. Growth performance metrics including mortality rates, average daily gain, and feed conversion can reveal subclinical disease effects. Vaccination records should document products used, administration dates, and any adverse reactions. All animal movements should be recorded to facilitate trace-back if disease is detected. Diagnostic test results and any clinical disease observations should be maintained in permanent records.

Economic considerations permeate all aspects of pseudorabies management, from prevention and control investments to treatment and culling decisions. The costs of vaccination programs, biosecurity infrastructure, testing, and veterinary services must be weighed against the potential losses from clinical disease, reproductive failure, regulatory restrictions, and market access limitations. In areas where pseudorabies has been eradicated, maintaining freedom from reintroduction protects access to domestic and international markets. Insurance options may be available to protect against catastrophic losses from disease outbreaks. Cost-benefit analysis should guide decisions about participation in official control and eradication programs, investment in facilities and equipment, and individual animal treatment versus culling decisions.

All breeds and genetic lines of domestic swine are susceptible to pseudorabies infection, with no recognized breed-related resistance or predisposition. The widespread susceptibility reflects the relatively recent divergence of domestic pig breeds and the absence of selection pressure for pseudorabies resistance in breeding programs. Commercial crossbred pigs used in intensive production systems and heritage or rare breeds maintained in smaller operations are equally vulnerable to infection. The universal susceptibility means that biosecurity and vaccination remain the primary tools for protection regardless of the genetic background of the herd.

Production type significantly influences pseudorabies risk and management approach, even though it does not affect inherent susceptibility. Breeding herds face particular risks because reproductive failure is a primary manifestation of infection and because latently infected breeding animals serve as ongoing sources of virus for their offspring and contacts. Farrow-to-finish operations must protect multiple age groups with varying susceptibility and clinical outcomes. Feeder pig producers purchasing animals from multiple sources face elevated introduction risks, while finishing operations receiving feeder pigs may introduce infection if supplier herds are not properly screened. Outdoor and pasture-based production systems face unique challenges in preventing contact with feral swine and wildlife.

Genetic selection and testing for pseudorabies focus on identifying and eliminating infected individuals rather than selecting for disease resistance. The availability of marker vaccines and differential diagnostic tests allows identification of infected animals within vaccinated populations, facilitating test-and-removal strategies for herd cleanup. Nucleus and multiplier herds producing breeding stock must maintain stringent biosecurity and monitoring programs to prevent transmission to customer herds. Artificial insemination centers face particular scrutiny because infected semen can transmit virus to multiple herds. Industry programs for pseudorabies control and eradication typically begin with breeding stock suppliers and cascade through the production pyramid to commercial farms.

Pseudorabies frequently co-occurs with other respiratory and reproductive pathogens that circulate in swine populations. Porcine reproductive and respiratory syndrome virus is commonly present in herds affected by pseudorabies and may complicate diagnosis and increase disease severity through immunosuppression. Swine influenza, Mycoplasma hyopneumoniae, and various bacterial pathogens can contribute to respiratory disease complex in growing pigs already challenged by pseudorabies virus. The stress and immunosuppression associated with pseudorabies infection may trigger or exacerbate concurrent infections that would otherwise remain subclinical. Comprehensive herd health programs should address multiple pathogens rather than focusing exclusively on pseudorabies.

Several conditions produce clinical signs similar to pseudorabies and must be considered in differential diagnosis. Classical swine fever and African swine fever cause reproductive failure, neurological signs, and high mortality in swine, though they lack the intense pruritus seen in non-swine species with pseudorabies. Bacterial meningitis from Streptococcus suis or other organisms can cause neurological signs in pigs of various ages. Rabies must be differentiated from pseudorabies in all species, though the intense itching characteristic of pseudorabies is rarely seen with rabies. Salt poisoning produces neurological signs in pigs with characteristic eosinophilic meningoencephalitis. Teschen-Talfan disease causes paralysis in pigs that may resemble pseudorabies.

Complications and sequelae of pseudorabies infection extend beyond the acute disease phase in animals that survive. Permanent neurological deficits may persist in recovered animals, affecting coordination, sensory function, or behavior. Secondary bacterial infections commonly complicate respiratory involvement and may require prolonged antimicrobial therapy. Reproductive recovery in breeding animals may be slow, with impaired conception rates and litter sizes persisting for multiple cycles after infection. The chronic carrier state in recovered pigs creates ongoing management challenges and potential for transmission to susceptible animals. In herds undergoing elimination programs, the extended persistence of latent infection complicates certification of freedom from disease.